Tweet by Neurology Journal on Twitter. Bio markers Alzheimer’s.

Neurology Journal ⁦‪@GreenJournal‬⁩ This study provides Class II evidence that CSF levels of β-synuclein, α-synuclein, SNAP-25, neurogranin, and NfL are higher in patients with Alzheimer disease than in patients with Lewy body disease. Read the article: bit.ly/3pANlt9 #NeuroTwitter pic.twitter.com/T9eYdztFZd 7/8/23, 4:40 AM Joseph Thornton

Tweet by Chris Palmer, MD on brain obesity

Chris Palmer, MD ⁦‪@ChrisPalmerMD‬⁩ “Obesity may lead to cognitive impairment and psychiatric disorders, which are associated with alterations in the brain cortical structure.” It’s not about fat shaming. It’s about a metabolic disorder affecting the brain. academic.oup.com/cercor/advance… 7/6/23, 4:58 PM Joseph Thornton

Tweet by Joshua Rosenblat, MD, MSc, Controlled study tDCS depression

Joshua Rosenblat, MD, MSc, FRCPC ⁦‪@JD_Rosenblat‬⁩ Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial ⁦‪@TheLancet‬⁩ thelancet.com/journals/lance… 7/6/23, 5:52 AM Joseph Thornton

Tweet by Chris Aiken, catatonia guidelines

Chris Aiken, MD ⁦‪@chrisaikenmd‬⁩ First guidelines on catatonia released, recommending benzos (lorazepam) or ECT 1st line; amantadine or memantine 2nd; and judicious use of #antipsychotics which can worsen the condition (they prefer atypicals with low D2 dopamine blockade) l8r.it/zP9o #psychiatry pic.twitter.com/u4NdLv5nKD 7/5/23, 5:20 PM Joseph Thornton